stockrowNatera, Inc.
NTRA Healthcare Diagnostics & Research
Natera, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 35.9% from fiscal 2024.
- Revenue
- +34.1%
- EPS
- +34.4%
- Free cash flow
- −85.8%
- Total debt
- −0.06%
Quarter to September 2026, against a year earlier
Follow NTRA
Alert me
Natera, Inc. (NTRA) EV/FCF
As of 5 November 2026, Natera, Inc. (NTRA) trades at a EV/FCF of 991×. Over the past ten years it has ranged from −632× (December 2024) to 1,183× (October 2026); the current reading is higher than 99% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 281× | 1.49% |
| FY2024 | 276× | — |
| FY2023 | −23.1× | — |
| FY2022 | −6.8× | — |
| FY2021 | −20.9× | — |
| FY2020 | −37.5× | — |
| FY2019 | −29.6× | — |
| FY2018 | −10.4× | — |
| FY2017 | −4.7× | — |
| FY2016 | −5.5× | — |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 1,121× | 147.30% |
| Jun 2026 | 453× | 71.79% |
| Mar 2026 | 264× | (5.94%) |
| Dec 2025 | 281× | 39.00% |
| 43 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| DGX Quest Diagnostics Incorporated compare | 23.8× |
| IQV IQVIA Holdings Inc. compare | 27.5× |
| LH Labcorp Holdings Inc. compare | 29.8× |
| ILMN Illumina, Inc. compare | 31.3× |
| A Agilent Technologies, Inc. compare | 39.7× |
| IDXX IDEXX Laboratories, Inc. compare | 40.7× |
| MTD Mettler-Toledo International, Inc. compare | 41.4× |
| WAT Waters Corporation compare | 190× |
| NTRA Natera, Inc. | 991× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on NTRA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement